Health authorities have warned patients taking antidepressants, including children and teenagers, that signs of worsening depression and suicidal thoughts should be monitored.
The warning comes after a panel of experts in February 2004 called on the FDA to issue stronger warnings to patients taking antidepressants. Health officials have not yet reached a final conclusion about the drugs safety, but studies continue.
GlaxoSmithKline’s antidepressant, paroxetine (Paxil[R]), raised safety concerns after regulators reviewed its clinical trials. Citalopram (Celexa[TM]), fluvoxamine (Luvox[R]), mirtazapine (Remeron[R]), nefazodone (Serzone[R]), sertraline (Zoloft[R]), fluoxetine (Proza[R]), and venlafaxine (Effexor[R]) are also being re-evaluated.
Most Popular
Sales Compensation - A Guide for Sales Operations
FREE Economist Report available at the Cisco Collaboration Resource Center
Business Ethics Policy
Pricing in a Proliferating World
Choosing Good Employees For Your Business
The FDA has advised patients and doctors to be more aware of signs of hostility, anxiety, insomnia, and other depression-related thoughts.
COPYRIGHT 2003 Vegetus Publications
COPYRIGHT 2005 Gale Group